|
29 juliol 2020 |
Altered glycosylation in pancreatic cancer: development of new tumor markers and therapeutic strategies |
Guerrero Barrado, Pedro Enrique
|
|
setembre 2018 |
Biomarcadors moleculars no invasius pel cà ncer de pà ncrees |
Mattioli Borrull, Romana
|
|
19 març 2004 |
Glicosilació aberrant en proteïnes de secreció com a marcadors tumorals |
Tabarés Carreras, Glòria
|
|
|
Glicosilació aberrant en proteïnes de secreció com a marcadors tumorals |
Tabarés Carreras, Glòria
|
|
10 febrer 2011 |
Glycan alterations of serum proteins as tumour markers. Prostate-specific antigen in prostate cancer and acute-phase proteins in pancreatic cancer |
Sarrats Carbó, Ariadna
|
|
|
Glycan alterations of serum proteins as tumour markers. Prostate-specific antigen in prostate cancer and acute-phase proteins in pancreatic cancer |
Sarrats Carbó, Ariadna
|
|
setembre 2017 |
Glycomic and glycoproteomic approaches :|bpotential tools for the improvement of the gold standard biomarker for prostate cancer diagnosis |
Domènech GarcÃa, Heura
|
|
|
Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin |
Balmaña, Meritxell
; Sarrats Carbó, Ariadna
; Llop Escorihuela, Esther
; Barrabés Vera, SÃlvia
; Saldova, Radka
; Ferri Iglesias, MarÃa José
; Figueras, Joan
; Fort Martorell, Esther
; Llorens Duran, Rafael de
; Rudd, Pauline M.
; Peracaula Miró, Rosa
|
|
març 2015 |
Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin |
Balmaña, Meritxell
; Sarrats Carbó, Ariadna
; Llop Escorihuela, Esther
; Barrabés Vera, SÃlvia
; Saldova, Radka
; Ferri Iglesias, MarÃa José
; Figueras, Joan
; Fort Martorell, Esther
; Llorens Duran, Rafael de
; Rudd, Pauline M.
; Peracaula Miró, Rosa
|
|
|
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology |
Ferri Iglesias, MarÃa José
; Sáez Zafra, Marc
; Figueras, Joan
; Fort Martorell, Esther
; SÃ bat Mir, MÃriam
; López-Ben, Santiago
; Llorens Duran, Rafael de
; Aleixandre i Cerarols, Rosa Núria
; Peracaula Miró, Rosa
|
|
1 juny 2018 |
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology |
|
|
5 juny 2018 |
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology |
Ferri Iglesias, MarÃa José
; Sáez Zafra, Marc
; Figueras, Joan
; Fort Martorell, Esther
; SÃ bat Mir, MÃriam
; López-Ben, Santiago
; Llorens Duran, Rafael de
; Aleixandre i Cerarols, Rosa Núria
; Peracaula Miró, Rosa
|
|
25 gener 2016 |
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology |
Ferri Iglesias, MarÃa José
; Sáez Zafra, Marc
; Figueras, Joan
; Fort Martorell, Esther
; SÃ bat Mir, MÃriam
; López-Ben, Santiago
; Llorens Duran, Rafael de
; Aleixandre i Cerarols, Rosa Núria
; Peracaula Miró, Rosa
|
|
15 febrer 2020 |
Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology |
Ferri Iglesias, MarÃa José
; Sáez Zafra, Marc
; Figueras, Joan
; Fort Martorell, Esther
; SÃ bat Mir, MÃriam
; López-Ben, Santiago
; Llorens Duran, Rafael de
; Aleixandre i Cerarols, Rosa Núria
; Peracaula Miró, Rosa
|
|
|
Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer |
Balmaña, Meritxell
; Giménez, Estela
; Puerta, Angel
; Llop Escorihuela, Esther
; Figueras, Joan
; Fort Martorell, Esther
; Sanz Nebot, MarÃa Victoria
; Bolòs, Carme de
; Rizzi, Andreas
; Barrabés Vera, SÃlvia
; Frutos, Mercedes de
; Peracaula Miró, Rosa
|
|
30 gener 2016 |
Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer |
Balmaña, Meritxell
; Giménez, Estela
; Puerta, Angel
; Llop Escorihuela, Esther
; Figueras, Joan
; Fort Martorell, Esther
; Sanz Nebot, MarÃa Victoria
; Bolòs, Carme de
; Rizzi, Andreas
; Barrabés Vera, SÃlvia
; Frutos, Mercedes de
; Peracaula Miró, Rosa
|
|
|
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez MartÃn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; Cufà González, SÃlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez MartÃnez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
|
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez MartÃn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; Cufà González, SÃlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez MartÃnez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
1 juny 2018 |
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
|
|
5 juny 2018 |
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez MartÃn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz, Rosa
; Cufà González, SÃlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez MartÃnez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
2011 |
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |
Oliveras Ferrarós, Cristina
; Vázquez MartÃn, Alejandro
; Queralt, Bernardo
; Adrados, Manuel
; Ortiz Duran, Maria Rosa
; Cufà González, SÃlvia
; Hernández Yagüe, Xavier
; Guardeño, Raquel
; Báez, Luciana
; Martin Castillo, Begoña
; Pérez MartÃnez, Maria Carmen
; López Bonet, Eugeni
; Llorens Duran, Rafael de
; Bernadó, Luis
; Brunet i Vidal, Joan
; Menéndez Menéndez, Javier Abel
|
|
juny 2016 |
Modelització de les diverses glicoformes de l’antigen prostà tic especÃfic (PSA) |
Palomanes Jimenez, Aitor
|
|
|
Modelització de les diverses glicoformes de l’antigen prostà tic especÃfic (PSA) |
Palomanes Jimenez, Aitor
|
|
27 setembre 2012 |
Moléculas séricas relacionadas con la fisiopatologÃa del adenocarcinoma pancreático como posibles marcadores tumorales |
Ferri Iglesias, MarÃa José
|
|
|
Moléculas séricas relacionadas con la fisiopatologÃa del adenocarcinoma pancreático como posibles marcadores tumorales |
Ferri Iglesias, MarÃa José
|